Novartis

HYCAMTIN

Manufacturer:

Novartis

Hycamtin HCPCS:

J8705

HCPCS Code Descriptor:

Topotecan, oral, 0.25 mg

Category:

J Code

Hycamtin NDCs:

00078-0673-01, 00078-0672-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Hycamtin:

HYCAMTIN is an Oncology drug manufactured by Novartis and administered via the Oral route of administration. The J Code: J8705 is aligned to the drug HYCAMTIN.

ACCESS PRICING AND MORE BY REGISTERING

J8705 Added Date:

January 1, 2009

J8705 Effective Date:

January 1, 2019

J8705 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Hycamtin billing and coding information.
Hycamtin patient assistance information can be found through Novartis Patient Support at the URL: https://www.patient.novartisoncology.com/financial-assistance/pano/
HYCAMTIN prescribing information can be found at the link below:
Information regarding HYCAMTIN’s side effects can be found at MedlinePlus